BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37817028)

  • 1. N
    Tang B; Bi L; Xu Y; Cao L; Li X
    Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37817028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N6-methyladenosine reader protein IGF2BP1 suppresses CD8 + T cells-mediated tumor cytotoxicity and apoptosis in colon cancer.
    Peng Y; Zhang Z; Yang G; Dai Z; Cai X; Liu Z; Yun Q; Xu L
    Apoptosis; 2024 Apr; 29(3-4):331-343. PubMed ID: 37848671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N
    Luo F; Lin K
    Exp Cell Res; 2022 Aug; 417(1):113176. PubMed ID: 35489385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N
    Wang Y; Jin P; Wang X
    Apoptosis; 2024 Feb; 29(1-2):142-153. PubMed ID: 37698736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N
    Liu Z; Wang T; She Y; Wu K; Gu S; Li L; Dong C; Chen C; Zhou Y
    Mol Cancer; 2021 Aug; 20(1):105. PubMed ID: 34416901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA.
    Ni Z; Sun P; Zheng J; Wu M; Yang C; Cheng M; Yin M; Cui C; Wang G; Yuan L; Gao Q; Li Y
    Cancer Res; 2022 May; 82(9):1789-1802. PubMed ID: 35502544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric Regulation of IGF2BP1 as a Novel Strategy for the Activation of Tumor Immune Microenvironment.
    Liu Y; Guo Q; Yang H; Zhang XW; Feng N; Wang JK; Liu TT; Zeng KW; Tu PF
    ACS Cent Sci; 2022 Aug; 8(8):1102-1115. PubMed ID: 36032766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM29 promotes antitumor immunity through enhancing IGF2BP1 ubiquitination and subsequent PD-L1 downregulation in gastric cancer.
    Jiang T; Xia Y; Li Y; Lu C; Lin J; Shen Y; Lv J; Xie L; Gu C; Xu Z; Wang L
    Cancer Lett; 2024 Jan; 581():216510. PubMed ID: 38029830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N
    Wan W; Ao X; Chen Q; Yu Y; Ao L; Xing W; Guo W; Wu X; Pu C; Hu X; Li Z; Yao M; Luo D; Xu X
    Mol Cancer; 2022 Feb; 21(1):60. PubMed ID: 35197058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M
    Qiu X; Yang S; Wang S; Wu J; Zheng B; Wang K; Shen S; Jeong S; Li Z; Zhu Y; Wu T; Wu X; Wu R; Liu W; Wang HY; Chen L
    Cancer Res; 2021 Sep; 81(18):4778-4793. PubMed ID: 34301762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressive function of IGF2BP1 in gastric cancer through decreasing MYC.
    Ding N; Cao G; Wang Z; Xu S; Chen W
    Cancer Sci; 2024 Feb; 115(2):427-438. PubMed ID: 38115228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LRPPRC facilitates tumor progression and immune evasion through upregulation of m
    Wang H; Tang A; Cui Y; Gong H; Li H
    Front Immunol; 2023; 14():1144774. PubMed ID: 37063837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF2BP1 overexpression stabilizes PEG10 mRNA in an m6A-dependent manner and promotes endometrial cancer progression.
    Zhang L; Wan Y; Zhang Z; Jiang Y; Gu Z; Ma X; Nie S; Yang J; Lang J; Cheng W; Zhu L
    Theranostics; 2021; 11(3):1100-1114. PubMed ID: 33391523
    [No Abstract]   [Full Text] [Related]  

  • 14. Abrine, an IDO1 inhibitor, suppresses the immune escape and enhances the immunotherapy of anti-PD-1 antibody in hepatocellular carcinoma.
    Liang X; Gao H; Xiao J; Han S; He J; Yuan R; Yang S; Yao C
    Front Immunol; 2023; 14():1185985. PubMed ID: 37334368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N
    Yuan B; Zhou J
    PeerJ; 2023; 11():e14591. PubMed ID: 36691477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. m
    Liang A; Liu J; Wei Y; Liao Y; Wu F; Ruan J; Li J
    PeerJ; 2023; 11():e14954. PubMed ID: 37009154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP7 Enables Immune Escape of Glioma Cells by Regulating PD-L1 Expression.
    Li B; Wang B
    Immunol Invest; 2022 Oct; 51(7):1921-1937. PubMed ID: 35852892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanism of lncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR/PD-L1/USP8 axis.
    Huang Y; Xia L; Tan X; Zhang J; Zeng W; Tan B; Yu X; Fang W; Yang Z
    Cell Mol Biol Lett; 2022 Jun; 27(1):43. PubMed ID: 35658874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1/PKM2 pathway.
    Lv J; Li K; Yu H; Han J; Zhuang J; Yu R; Cheng Y; Song Q; Bai K; Cao Q; Yang H; Yang X; Lu Q
    J Exp Clin Cancer Res; 2023 Feb; 42(1):41. PubMed ID: 36747239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF2BP1 Bolsters the Chondrocytes Ferroptosis of Osteoarthritis by Targeting m
    Zhao Z; Dong S; Yang Y; Yin H; Xiong G; Ma J
    Int J Gen Med; 2024; 17():2433-2443. PubMed ID: 38826510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.